country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

16 Results for "

intestinal structure

" in MedChemExpress (MCE) Product Catalog:

Products (16)

Sort by :

Categories

By Targets

Products

Flubendazole

7 Publications Verification

Cat. No.: HY-B0294

CAS No.: 31430-15-6

Target:

Parasite Microtubule/Tubulin STAT MDM-2/p53 Apoptosis Autophagy

Research Areas:

Infection Cancer

Flubendazole is an anthelmintic drug based on altering microtubule structure, inhibition of tubulin polymerization and disruption of microtubule function. Flubendazole induces apoptosis in human colorectal cancer (CRC) by blocking the STAT3 signaling axis and activation of autophagy. Flubendazole induces P53 expression and reduced Cyclin B1 and p-cdc2 expression. Flubendazole is an antitumor agent. Flubendazole can be used for worm and intestinal parasites .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

Lacto-N-tetraose

1 Cited Publications

Cat. No.: HY-N9448

CAS No.: 14116-68-8

Category:

Infection Human Gut Microbiota Metabolites Polysaccharides Endogenous metabolite Disease Research Fields Inflammation/Immunology Saccharides

Target:

Bacterial

Lacto-N-tetraose is the significant core structure of human milk oligosaccharides (HMOs) naturally existing in human milk. Lacto-N-tetraose is consist of galactose, N-acetylglucosamine, and glucose moieties. Lacto-N-tetraose has prebiotic effect, immune regulatory effect, anti-inflammatory effects, intestinal cell responses regulatory effect, antibacterial activity and antiviral activity. Lacto-N-tetraose has been widely added to infant formula .

Compare